CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...
An announcement from Liquidia Technologies ( ($LQDA) ) is now available. On October 27, 2025, Liquidia Technologies entered into an exclusive ...
An organization that has been a staple in the community for more than 100 years had to furlough its employees amid funding delays. Luckily, the closure was ...
The capacity of the Marana detention center is 500 people. In 2017, when the population of the private prison was near ...
Key Features to Consider in the Best Nebulizer Machine in India - Have you ever bought a health device that ended up ...
The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR ...
About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the ...
As cooler temperatures and shifting air quality arrive, many families notice changes in their breathing. Dry air, allergens, ...
Air pollution was a major factor in the family deciding to relocate. Prashant Kalra's three-year-old daughter suffered breathing problems during their time in Gurgaon. 'She would have had full-blown ...